Abstract
 
 

ABSTRACT

INTRODUCTION

Ischaemic heart disease (IHD) is a major determinant of perioperative morbidity and mortality. Studies report operative-related reinfarction or cardiac death risks of 30% for patients within 3 months, and 5% within 6 months post-myocardial infarction.1 Preoperative beta-blocker use in IHD has been shown to reduce cardiovascular mortality and myocardial ischaemia after surgery. The European Society of Cardiology recommends that beta-blockers should be continued up to and including the morning of surgery.2 We investigated whether these guidelines were being followed at our hospital.

 
 
 


© JAYPEE BROTHERS MEDICAL PUBLISHERS (P) LTD.